Latest Eisai News & Updates

See the latest news and media coverage for Eisai. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Eisai

Human health care company

eisai.com
Headquarters
Bunkyo-Ku, Japan
Company type
Public company
Number of employees
1,000–5,000

Last updated

Latest news about Eisai

In short: Eisai announced a $7 billion three-year investment plan and aims for $7 billion in revenue by 2028, driven by the expansion of its Alzheimer's drug.

Company announcements

Eisai

Eisai opens new Global Capability Centre

The IT hub in Visakhapatnam, India, standardizes global IT operations and drives digital transformation. An opening ceremony celebrated its launch.

Eisai

Eisai ranks 36th in Global 100 sustainability list

It marks Eisai's tenth inclusion and highest rank among global pharmaceutical companies. Evaluation based on UN SDGs, sustainable revenue, and investment.

Unlock all announcements with a

Media coverage

Nikkei

Eisai stock falls as SBI Securities lowers target price

(1:40 p.m., Prime, code 4523) Eisai is falling. It hit 3873 yen in the afternoon, down 96 yen (2.41%) from the previous day. SBI Securities lowered its target price for Eisai from the previous 4740 yen to 3930 yen in a report dated the 18th, and selling appears to be driven by this news. The investment rating remains at "neutral," the middle of three levels. Regarding the first administration of the subcutaneous injection formulation of the Alzheimer's disease treatment drug "Leqembi" being developed by the company, the U.S. Food and Drug Administration (FDA...

Nikkei

Eisai invests 10 billion yen in the UK

We will send newsletters and campaign information for the Nikkei electronic edition to the email address you registered (you can unsubscribe after registration). We will use your email address only for the purpose of sending these emails. You will not be automatically registered for other services such as Nikkei ID. Thank you for registering. We have sent an email to the email address you provided. Click the link in the email to read the full article...

Fierce Pharma

Eisai snares government manufacturing grant as it brings Leqembi packaging to UK with $65M expansion

As the United Kingdom juggles industry concerns about the region's waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the...

Unlock all articles with a

Never miss news about Eisai

Track Eisai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.